Levoverbenone
Chemical compound
- R05CA11 (WHO)
- (1S,5S)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one
- 1196-01-6 Y
- 92874
- 83838 Y
- 2XP0J7754U
- CHEBI:78316 N
- ChEMBL2426701 N
- DTXSID9035620
- Interactive image
- O=C1\C=C(/[C@@H]2C[C@H]1C2(C)C)C
InChI
- InChI=1S/C10H14O/c1-6-4-9(11)8-5-7(6)10(8,2)3/h4,7-8H,5H2,1-3H3/t7-,8+/m0/s1 Y
- Key:DCSCXTJOXBUFGB-JGVFFNPUSA-N Y
Levoverbenone is an expectorant. It is the (−)-isomer of verbenone.[1]
References
- ^ Kutscher B, Kleemann A, eds. (2022). Ullmann's Pharmaceuticals. Vol. 2. Weinheim, Germany: John Wiley & Sons. p. 826. ISBN 978-3-527-80733-8.
External links
- "Levoverbenone". PubChem. National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine.
- v
- t
- e
Cough and cold preparations (R05)
- Acetylcysteine#
- Ambroxol
- Bromhexine
- Carbocisteine
- Dembrexine hydrochloride
- Domiodol
- Dornase alfa
- Eprazinone
- Erdosteine
- Letosteine
- Mannitol
- Mesna
- Neltenexine
- Sobrerol
- Stepronin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This stereochemistry article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e